Skip to content

Author

Pranav Shah

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Integrating in silico ADME modeling with Tox21 toxicity profiling to support compound prioritization

Toxicity remains a leading cause of late-stage attrition in drug development and is heavily influenced by a compound’s ADME (Absorption, Distribution, Metabolism, and Excretion) properties. The ability of a molecule to reach its target tissue, persist in circulation, or undergo bioactivation fundamentally shapes its...

Pranav Shah, C. Weber, Nivedita Kinatukara et al. · 0 citations
Open access Oct 2026

Novel 5-Phenylmorphans as Opioid Receptor Antagonists: Synthesis, Structure-Activity Relationship, Biological Evaluation and Computational Modeling

The widespread emergence of ultra-potent synthetic opioids in illicit drug supplies and the limited effectiveness of naloxone in reversing certain synthetic opioid overdoses highlight the urgent need for potent high-affinity opioid antagonists. This study describes an improved synthetic approach and structure-activity...

Z. Hasanpour, Dan Luo, T. Prisinzano et al. · 0 citations
Open access Sep 2026

Advancements in Forecasting Liver Cytosol Metabolic Stability: A Comprehensive Update on Machine Learning Predictive Models

Drug metabolism plays a key role in determining a compound’s pharmacokinetics and overall success in development. While cytochrome P450 enzymes have been widely studied, non-cytochrome P450 enzymes, such as aldehyde oxidase, xanthine oxidase, and carboxylesterases, are increasingly recognized as important contrib...

Gyutae Lim, Sankalp Jain, Xin Xu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.